Golden State Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4K | Sell |
83
-100
| -55% | -$12.6K | ﹤0.01% | 1068 |
|
|
2025
Q1 | $20.2K | Hold |
183
| – | – | ﹤0.01% | 795 |
|
|
2024
Q4 | $25K | Buy |
+183
| New | +$25K | ﹤0.01% | 714 |
|
|
2020
Q2 | – | Sell |
-54
| Closed | -$5K | – | 632 |
|
|
2020
Q1 | $5K | Buy |
+54
| New | +$5K | ﹤0.01% | 746 |
|
|
2019
Q4 | – | Sell |
-54
| Closed | -$5K | – | 607 |
|
|
2019
Q3 | $5K | Sell |
54
-946
| -95% | -$87.6K | ﹤0.01% | 862 |
|
|
2019
Q2 | $84K | Buy |
1,000
+500
| +100% | +$42K | 0.03% | 355 |
|
|
2019
Q1 | $44K | Buy |
+500
| New | +$44K | 0.01% | 476 |
|